The record
Written from the 1 report below. Nothing here is unsourced.
The Food Safety and Standards Authority of India (FSSAI) is taking action against Nestle India for allegedly using prohibited marketing claims for its infant nutritional products, specifically 'NAN Excella Pro Stage 1' and 'Lactogen Pro 1'. FSSAI states that promotional statements used on e-commerce platforms violate the Food Safety and Standards Act of 2020 and the 1992 Infant Milk Substitutes Act. Additionally, laboratory tests revealed that Nestle's follow-up formula contained lower-than-required levels of biotin.
Coverage1
All filed from India
Named India · IN-KA · Lactogen Pro 1 · NAN Excella Pro Stage 1 · Nestle India · Food Safety and Standards Authority of India
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.